Bishop's score

  • 文章类型: Journal Article
    为了比较宫颈成熟时间与使用阴道米索前列醇加Hyoscine-N-丁基溴,单独使用米索前列醇阴道。
    一项双盲随机对照试验,泛非临床试验注册(PACTR)批准号为PACTR202112821475292。
    联邦医疗中心,Asaba,尼日利亚。
    共纳入126名符合产前宫颈成熟的患者。
    A组的参与者有25微克阴道米索前列醇和1毫升肌内安慰剂,B组中的患者有25µg阴道米索前列醇和20mg肌内Hyoscine(1ml)。当需要时使用催产素输注,劳动按照部门协议进行监督。
    宫颈成熟时间。
    hyoscine组的平均宫颈成熟时间(8.48±4.36小时)明显短于安慰剂组(11.40±7.33小时);p值0.02,95%CI0.80-5.05。A组(7.38±5.28小时)平均诱导-分娩间期与B组(7.75±5.04小时)比较,差异无统计学意义,值为0.54。交付方式具有可比性。然而,B组女性(53,84.1%)的阴道分娩率高于A组女性(50,79.4%);p值0.49.甲组13名妇女(20.6%)剖腹产,B组中有10名妇女(15.9%)进行了剖腹产(p值0.49,RR0.94,CI0.80-1.11)。两组间不良母婴结局无统计学意义。
    当用作阴道米索前列醇的辅助药物时,肌内hyoscine可有效减少宫颈成熟时间,没有明显的不良母婴结局。
    没有声明。
    UNASSIGNED: To compare cervical ripening time with the use of vaginal Misoprostol plus Hyoscine-N-Butylbromide, with vaginal Misoprostol alone.
    UNASSIGNED: A double-blind randomized controlled trial with Pan-African Clinical Trials Registry (PACTR) approval number PACTR202112821475292.
    UNASSIGNED: Federal Medical Centre, Asaba, Nigeria.
    UNASSIGNED: A total of 126 eligible antenatal patients for cervical ripening were enrolled.
    UNASSIGNED: Participants in Group A had 25µg of vaginal misoprostol with 1ml of intramuscular placebo, and those in Group B had 25µg of vaginal misoprostol with 20mg of Intramuscular Hyoscine (1 ml). Oxytocin infusion was used when indicated, and the labour was supervised as per departmental protocol.
    UNASSIGNED: Cervical ripening time.
    UNASSIGNED: The mean cervical ripening time was statistically significantly shorter in the hyoscine group (8.48±4.36 hours) than in the placebo group (11.40±7.33 hours); p-value 0.02, 95% CI 0.80-5.05. There was no statistically significant difference in the mean induction-delivery interval in Group A (7.38±5.28 hours) compared to Group B (7.75±5.04 hours), with a value of 0.54. The mode of delivery was comparable. However, women in Group B (53, 84.1%) achieved more vaginal deliveries than women in Group A (50, 79.4%); p-value 0.49. Thirteen women in Group A (20.6%) had a caesarean section, while ten women (15.9%) in Group B had a caesarean section (p-value 0.49, RR 0.94, CI 0.80-1.11). Adverse maternal and neonatal outcomes were not statistically significant between the two groups.
    UNASSIGNED: Intramuscular hyoscine was effective in reducing cervical ripening time when used as an adjunct to vaginal Misoprostol, with no significant adverse maternal or neonatal outcome.
    UNASSIGNED: None declared.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    OBJECTIVE: Our objectives were to confirm the predictiveness of parity for successful labor induction and propose an improvement in the Bishop\'s score to take parity into account and simultaneously simplify the original Bishop score.
    METHODS: Retrospective study of 326 deliveries induced by oxytocin and amniotomy before prostaglandins between January 1, 1987, and June 30, 1988. We conducted a univariate and then a multivariate analysis of the relation between successful labor induction - defined by vaginal delivery- and the components of Bishop\'s score and parity.
    RESULTS: Nulliparous accounted for 38% of the studied population. The mean Bishop at induction was 5.75±1.4. Fetal station, cervical effacement, and parity were the only factors associated with the success of induction in this study. Removing the cervical position and consistency from the score as well as adding parity significantly improved the prediction of success (ROC curves, AUC 0.88 vs 0.68, p<0.001). By taking 5% as the maximum risk of induction failure, a cutoff point of 4 for the new score makes it possible to induce labor in 90% of the women that were considered in the study (vs 26% or 60%, according to whether the cutoff point of the original Bishop\'s score is set, respectively, at 7 or 6, p<0.001).
    CONCLUSIONS: Cervical position and consistency are not necessary for predicting successful labor induction by oxytocin and amniotomy. We confirmed the usefulness of a simplified Bishop score that considers parity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号